Venous thromboembolism: Difference between revisions

Jump to navigation Jump to search
Line 162: Line 162:
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[Hormonal therapy]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[Hormonal therapy]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1
|}
==IMPROVE Predictive Score for VTE==
===Calculation of the IMPROVE Predictive Score===
{| style="cellpadding=0; cellspacing= 0; width: 600px;"
|-
| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Variable'''||style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Score'''<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241  }} </ref>
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | Prior episode of [[VTE]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | 3
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Thrombophilia]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |3
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Malignancy]]||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Age more than 60 years|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1
|}
===Interpretation of the IMPROVE Predictive Score===
{| style="cellpadding=0; cellspacing= 0; width: 600px;"
|-
| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Score'''||style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Predicted VTE risk through 3 months'''<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241  }} </ref>
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | 0|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |0.5%
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1.0%
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1.7%
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |3|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |3.1%
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |4|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |5.4%
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |5-8|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |11%
|}
|}
<references />
<references />

Revision as of 15:55, 12 October 2017

Venous thromboembolism Microchapters

Patient Information

Deep vein thrombosis
Pulmonary embolism

Overview

Classification

Epidemiology

Risk Factors

Diagnosis

Treatment

Deep Vein Thrombosis
Pulmonary Embolism

Prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]:Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]

Overiew

Classification

Venous thromboembolism (VTE) may be classified into:[1]

  • Deep vein thrombosis (DVT)
  • Pulmonary embolism (PE)

The following table further classifies DVT and PE:[2][3][4][5][4][6][7][8]

Classification of Venous thromboembolism
Clinical diagnosis Sub-classification Comments
Deep vein thrombosis Upper extremity
  • Uncommon and accounts for 1-5 % of all DVT
  • Most likely due to:
    • Central venous catheter
    • Cardiac pacemaker
    • Implantable cardioverter defibrillator
    • Effort thrombosis (Paget–Schroetter disease)
    • Cancer
Lower extremity
  • Proximal:
    • Popliteal veins
    • Femoral veins
    • Iliac veins
  • Isolated distal:
    • Calf veins (Peroneal, soleal, posterior tibial, gastrocnemial, soleal, gastrocnemial, peroneal, posterior tibial)
Pulmonary embolism (PE) Massive PE (High risk)
  • Sustained hypotension (systolic blood pressure <90 mm Hg), not due to arrhythmia, hypovolemia, sepsis, or left ventricular dysfunction, and either lasting for at least 15 minutes or necessitating the administration of inotropes

OR

  • Pulselessness

OR

  • Persistent profound bradycardia (heart rate < 40 bpm) plus findings of shock
Sub-massive PE (Intermediate risk PE)
  • Right ventricular dysfunction OR myocardial necrosis

AND

  • Absence of systemic hypotension (systolic blood pressure >90 mm Hg)
Low risk PE

Epidemiology

Risk Factors

Shown below is a list of predisposing factors for VTE.[9][10] The risk factors are classified as moderate or weak depending on how strongly they predispose for a VTE.

Moderate risk factors Weak risk factors
Chemotherapy

Chronic heart failure
Respiratory failure
Hormone replacement therapy
Cancer
Oral contraceptive pills
Stroke
Pregnancy
Postpartum
❑ Prior history of VTE
Thrombophilia

❑ Advanced age

Laparoscopic surgery
❑ Prepartum
Obesity
Varicose veins

Risk factors of VTE may be categorized in to modifiable, non-modifiable, temporary and other risk factors.

Modifiable Risk Factors Non-Modifiable Risk Factors Temporary Risk Factors Other Risk Factors

❑ Modifiable risk factors are reversible based upon lifestyle/behavior modification.
Obesity is defined as a body-mass index (BMI) above 30 kg/m2.[11] [12] [13]
Smoking:[11] Smoking significantly increases the risk of DVT, particularly among women who are taking oral contraceptive pills as well as among obese people.
❑ Use of oral contraceptives[14]
Hyperhomocysteinemia:[15] Hyperhomocysteinemia can be reduced with vitamin B supplementation.

❑ Advanced age
Heart failure
Thrombophilia or hypercoagulable state
Polycythemia vera

Factor V Leiden
Prothrombin G20210A mutation
Protein C deficiency
Protein S deficiency
Activated protein C resistance
Antithrombin III deficiency
Factor VIII mutation
Antiphospholipid syndrome
Heparin induced thrombocytopenia
Nephrotic syndrome
Paroxysmal nocturnal hemoglobinuria
❑ Advanced age

Pregnancy and the peri-partum period
❑ Active cancer
Central venous catheter

❑ Advanced age

❑ Other possible factors associated with VTE include:[16]

❑ Nutrition low in fish
Psychological stress
❑ Cardiovascular risk factors such as diabetes and hypercholesterolemia

Diagnosis

Treatment

Prevention

Risk Assessment

The following scoring systems can be used to assess the risk of VTE, based on risk factors:

Padua Prediction Score for VTE

Shown below is a table depicting Padua predictive score for VTE among hospitalized medical patients. The interpretation of the score is as follows:

  • Score≥ 4: High risk for VTE
  • Score< 4: Low risk for VTE[17]
Variable Score
Active cancer 3
Previous VTE 3
Decreased mobility 3
Thrombophilia 3
Previous trauma or surgery within that last month 2
Age≥ 70 1
Heart and/or respiratory failure 1
Ischemic stroke or acute myocardial infarction 1
Acute rheumatologic disorder and/or acute infection 1
Obesity 1
Hormonal therapy 1

IMPROVE Predictive Score for VTE

Calculation of the IMPROVE Predictive Score

Variable Score[18]
Prior episode of VTE 3
Thrombophilia 3
Malignancy 1
Age more than 60 years 1

Interpretation of the IMPROVE Predictive Score

Score Predicted VTE risk through 3 months[18]
0 0.5%
1 1.0%
2 1.7%
3 3.1%
4 5.4%
5-8 11%
  1. Moheimani F, Jackson DE (2011). "Venous thromboembolism: classification, risk factors, diagnosis, and management". ISRN Hematol. 2011: 124610. doi:10.5402/2011/124610. PMC 3196154. PMID 22084692.
  2. Anand SS, Wells PS, Hunt D, Brill-Edwards P, Cook D, Ginsberg JS (1998). "Does this patient have deep vein thrombosis?". JAMA. 279 (14): 1094–9. PMID 9546569. Unknown parameter |month= ignored (help)
  3. Wells PS, Hirsh J, Anderson DR; et al. (1995). "Accuracy of clinical assessment of deep-vein thrombosis". Lancet. 345 (8961): 1326–30. PMID 7752753. Unknown parameter |month= ignored (help)
  4. 4.0 4.1 Cogo A, Lensing AW, Prandoni P, Hirsh J (1993). "Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound". Arch. Intern. Med. 153 (24): 2777–80. PMID 8257253. Unknown parameter |month= ignored (help)
  5. Galanaud JP, Sevestre-Pietri MA, Bosson JL, Laroche JP, Righini M, Brisot D, Boge G, van Kien AK, Gattolliat O, Bettarel-Binon C, Gris JC, Genty C, Quere I (2009). "Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study". Thromb. Haemost. 102 (3): 493–500. doi:10.1160/TH09-01-0053. PMID 19718469. Retrieved 2011-12-14. Unknown parameter |month= ignored (help)
  6. Joffe HV, Kucher N, Tapson VF, Goldhaber SZ (2004). "Upper-extremity deep vein thrombosis: a prospective registry of 592 patients". Circulation. 110 (12): 1605–11. doi:10.1161/01.CIR.0000142289.94369.D7. PMID 15353493. Retrieved 2012-10-07. Unknown parameter |month= ignored (help)
  7. Isma N, Svensson PJ, Gottsäter A, Lindblad B (2010). "Upper extremity deep venous thrombosis in the population-based Malmö thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality". Thromb Res. 125 (6): e335–8. doi:10.1016/j.thromres.2010.03.005. PMID 20406709.
  8. Muñoz FJ, Mismetti P, Poggio R, Valle R, Barrón M, Guil M; et al. (2008). "Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry". Chest. 133 (1): 143–8. doi:10.1378/chest.07-1432. PMID 17925416.
  9. Anderson FA, Spencer FA (2003). "Risk factors for venous thromboembolism". Circulation. 107 (23 Suppl 1): I9–16. doi:10.1161/01.CIR.0000078469.07362.E6. PMID 12814980.
  10. Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galiè N, Pruszczyk P; et al. (2008). "Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)". Eur Heart J. 29 (18): 2276–315. doi:10.1093/eurheartj/ehn310. PMID 18757870.
  11. 11.0 11.1 Holst AG, Jensen G, Prescott E (2010). "Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study". Circulation. 121 (17): 1896–903. doi:10.1161/CIRCULATIONAHA.109.921460. PMID 20404252.
  12. Vayá A, Martínez-Triguero ML, España F, Todolí JA, Bonet E, Corella D (2011). "The metabolic syndrome and its individual components: its association with venous thromboembolism in a Mediterranean population". Metab Syndr Relat Disord. 9 (3): 197–201. doi:10.1089/met.2010.0117. PMID 21352080.
  13. Eichinger S, Hron G, Bialonczyk C, Hirschl M, Minar E, Wagner O; et al. (2008). "Overweight, obesity, and the risk of recurrent venous thromboembolism". Arch Intern Med. 168 (15): 1678–83. doi:10.1001/archinte.168.15.1678. PMID 18695082.
  14. Pomp ER, Rosendaal FR, Doggen CJ (2008). "Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use". Am J Hematol. 83 (2): 97–102. doi:10.1002/ajh.21059. PMID 17726684.
  15. den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH; et al. (1996). "Hyperhomocysteinemia as a risk factor for deep-vein thrombosis". N Engl J Med. 334 (12): 759–62. doi:10.1056/NEJM199603213341203. PMID 8592549.
  16. Konofal E, Lecendreux M, Cortese S (2010). "Sleep and ADHD". Sleep Med. 11 (7): 652–8. doi:10.1016/j.sleep.2010.02.012. PMID 20620109.
  17. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M; et al. (2010). "A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score". J Thromb Haemost. 8 (11): 2450–7. doi:10.1111/j.1538-7836.2010.04044.x. PMID 20738765.
  18. 18.0 18.1 Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH; et al. (2011). "Predictive and associative models to identify hospitalized medical patients at risk for VTE". Chest. 140 (3): 706–14. doi:10.1378/chest.10-1944. PMID 21436241.